ARTICLE | Company News

AVI BioPharma infectious, musculoskeletal news

December 19, 2011 8:00 AM UTC

AVI did not disclose the amount it expects to save from the restructuring, which it expects to complete by January 2012. At Sept. 30, AVI had $46.4 million in cash and a nine-month operating loss of $...